Ubiquinol-10

There are 4 papers on Ubiquinol-10 in aging research: 2 trials and 1 observational study in people, 1 in animals.

Biomarker

4 papers study it3 more mention it6 findings

MeSH

See all 7 papers on Ubiquinol-10

“Percent reductions of ubiquinol-10 and those of total cholesterol showed a positive correlation (r = 0.627, p = 0.0165).”
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patientsJournal of atherosclerosis and thrombosis2005doi:10.5551/jat.12.111
  • Human trial2
  • Humans1
  • Animals1

Interventions

2

Atorvastatin

downin humans1

1 study
  1. Atorvastatin decreases Ubiquinol-10 in humans (from 0.81 +/- 0.21 to 0.46 +/- 0.10 microg/ml (p < 0.0001)).

    “mean levels of serum ubiquinol-10 and ubiquinone-10 levels decreased significantly from 0.81 +/- 0.21 to 0.46 +/- 0.10 microg/ml (p < 0.0001)”

    Human trial10 mg/day8 weeksn = 14

    Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients

    Journal of atherosclerosis and thrombosis

More on Atorvastatin

Smoking

downin humans1

1 study
  1. Smoking is linked with lower Ubiquinol-10 in humans (smokers vs non-smokers) (P = 0.006 or P = 0.009).

    “plasma ubiquinol-10 was found to be reduced amongst smokers”

    Humanssmokers vs non-smokersplasma

    Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

    Atherosclerosis

More on Smoking

Upstream

2

Hypertension

downin humans1

1 study
  1. Hypertension is linked with lower Ubiquinol-10 in humans (hyperlipidaemic patients with hypertension vs without).

    “The hyperlipidaemic patients with hypertension had a lower proportion of ubiquinol-10 than subjects without.”

    Humanshyperlipidaemic patients with hypertension vs withoutplasma

    Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

    Atherosclerosis

More on Hypertension

Hyperlipidemia

downin humans1

1 study
  1. Hyperlipidemia is linked with lower Ubiquinol-10 in humans (hyperlipidaemic patients vs healthy controls) (P = 0.001 and 0.008).

    “Plasma ubiquinol-10, expressed as a percentage of total ubiquinol-10 + ubiquinone-10 or normalized to plasma lipids, was lower in the patients than in controls”

    Humanshyperlipidaemic patients vs healthy controlsplasma

    Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

    Atherosclerosis

More on Hyperlipidemia

Associations

2

Total cholesterol

upin humans1

1 study
  1. Ubiquinol-10 is associated with total cholesterol in humans (r = 0.627, p = 0.0165).

    “Percent reductions of ubiquinol-10 and those of total cholesterol showed a positive correlation (r = 0.627, p = 0.0165).”

    Human trial10 mg/day8 weeksn = 14

    Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients

    Journal of atherosclerosis and thrombosis

More on Total cholesterol

Triglyceride

downin humans1

1 study
  1. Triglyceride is associated with Ubiquinol-10 in humans.

    “A negative correlation was found between the proportion of ubiquinol-10 and plasma triglycerides.”

    Humansplasma

    Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

    Atherosclerosis

More on Triglyceride

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months